|
ELP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.72760036779118E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.3514966923367E-11 |
| Normal-vs-Stage2 |
1.260270E-03 |
| Normal-vs-Stage3 |
6.157000E-03 |
| Normal-vs-Stage4 |
8.239800E-03 |
| Stage1-vs-Stage2 |
7.493800E-01 |
| Stage1-vs-Stage3 |
8.876500E-03 |
| Stage1-vs-Stage4 |
4.654500E-02 |
| Stage2-vs-Stage3 |
1.477400E-01 |
| Stage2-vs-Stage4 |
2.574400E-01 |
| Stage3-vs-Stage4 |
7.965200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.51820001015324E-10 |
| Normal-vs-AfricanAmerican |
8.161700E-02 |
| Normal-vs-Asian |
3.458800E-01 |
| Caucasian-vs-AfricanAmerican |
2.636200E-02 |
| Caucasian-vs-Asian |
6.709000E-01 |
| AfricanAmerican-vs-Asian |
7.193600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.39199999807482E-08 |
| Normal-vs-Female |
2.57200000186586E-08 |
| Male-vs-Female |
6.337000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.801800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.64039998146382E-09 |
| Normal-vs-Age(61-80Yrs) |
3.14779999954773E-07 |
| Normal-vs-Age(81-100Yrs) |
1.454790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.089400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.735600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.890600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.341000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.500800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.069600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.282800E-03 |
| Normal-vs-Grade 2 |
1.69797509386171E-12 |
| Normal-vs-Grade 3 |
5.84120000000077E-05 |
| Normal-vs-Grade 4 |
6.331400E-01 |
| Grade 1-vs-Grade 2 |
8.216400E-01 |
| Grade 1-vs-Grade 3 |
1.619400E-01 |
| Grade 1-vs-Grade 4 |
1.689590E-02 |
| Grade 2-vs-Grade 3 |
1.081570E-03 |
| Grade 2-vs-Grade 4 |
2.74659999999205E-06 |
| Grade 3-vs-Grade 4 |
2.371700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
4.079600E-02 |
| ccA subtype-vs-ccB subtype |
2.89010004816959E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.57299999984318E-08 |
| Normal-vs-N1 |
1.862170E-01 |
| N0-vs-N1 |
9.502000E-01 |
|
|
